Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Robert J Mark. (1999) Common mechanisms of oxidative damage in chronic neurodegenerative conditions: potential points of therapeutic intervention. Expert Opinion on Therapeutic Patents 9:10, pages 1339-1346.
Read now
Read now
Articles from other publishers (30)
Melika Zamani, Thomas Budde & Hooman Bozorgi. (2020) Intracerebroventricular administration of N-type calcium channel blocker ziconotide displays anticonvulsant, anxiolytic, and sedative effects in rats: A preclinical and pilot study. Epilepsy & Behavior 111, pages 107251.
Crossref
Crossref
P. Beswick. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
65
130
.
Charlotte Elisabet Tranberg, Aijun Yang, Irina Vetter, Jeffrey R. McArthur, Jonathan B. Baell, Richard J. Lewis, Kellie L. Tuck & Peter J. Duggan. (2012) ω-Conotoxin GVIA Mimetics that Bind and Inhibit Neuronal Cav2.2 Ion Channels. Marine Drugs 10:12, pages 2349-2368.
Crossref
Crossref
Hassan Pajouhesh, Zhong-Ping Feng, Lingyun Zhang, Hossein Pajouhesh, Xinpo Jiang, Adam Hendricson, Haiheng Dong, Elizabeth Tringham, Yanbing Ding, Todd W. Vanderah, Frank Porreca, Francesco Belardetti, Gerald W. Zamponi, Lester A. Mitscher & Terrance P. Snutch. (2012) Structure–activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors. Bioorganic & Medicinal Chemistry Letters 22:12, pages 4153-4158.
Crossref
Crossref
Dimitra Hadjipavlou-Litina. 2011. Ion Channels and Their Inhibitors. Ion Channels and Their Inhibitors
265
288
.
Gerald W. Zamponi, Zhong-Ping Feng, Lingyun Zhang, Hossein Pajouhesh, Yanbing Ding, Francesco Belardetti, Hassan Pajouhesh, David Dolphin, Lester A. Mitscher & Terrance P. Snutch. (2009) Scaffold-based design and synthesis of potent N-type calcium channel blockers. Bioorganic & Medicinal Chemistry Letters 19:22, pages 6467-6472.
Crossref
Crossref
Takashi Yamamoto, Seiji Niwa, Seiji Ohno, Munetaka Tokumasu, Yoko Masuzawa, Chika Nakanishi, Akira Nakajo, Tomoyuki Onishi, Hajime Koganei, Shin-ichi Fujita, Tomoko Takeda, Morikazu Kito, Yukitsugu Ono, Yuki Saitou, Akira Takahara, Seinosuke Iwata & Masataka Shoji. (2008) The structure–activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels. Bioorganic & Medicinal Chemistry Letters 18:17, pages 4813-4816.
Crossref
Crossref
Lars J.S. Knutsen, Christopher J. Hobbs, Christopher G. Earnshaw, Andrea Fiumana, Jenny Gilbert, Sarah L. Mellor, Fleur Radford, Nichola J. Smith, Philip J. Birch, J. Russell Burley, Stuart D.C. Ward & Iain F. James. (2007) Synthesis and SAR of novel 2-arylthiazolidinones as selective analgesic N-type calcium channel blockers. Bioorganic & Medicinal Chemistry Letters 17:3, pages 662-667.
Crossref
Crossref
Il Whea Ku, Sangwon Cho, Munikumar Reddy Doddareddy, Min Seok Jang, Gyochang Keum, Jung-Ha Lee, Bong Young Chung, Youseung Kim, Hyewhon Rhim & Soon Bang Kang. (2006) Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers. Bioorganic & Medicinal Chemistry Letters 16:19, pages 5244-5248.
Crossref
Crossref
Takashi Yamamoto, Seiji Niwa, Satoshi Iwayama, Hajime Koganei, Shin-ichi Fujita, Tomoko Takeda, Morikazu Kito, Yukitsugu Ono, Yuki Saitou, Akira Takahara, Seinosuke Iwata, Hiroshi Yamamoto & Masataka Shoji. (2006) Discovery, structure–activity relationship study, and oral analgesic efficacy of cyproheptadine derivatives possessing N-type calcium channel inhibitory activity. Bioorganic & Medicinal Chemistry 14:15, pages 5333-5339.
Crossref
Crossref
Christina Schroeder & Richard Lewis. (2006) ω-Conotoxins GVIA, MVIIA and CVID: SAR and Clinical Potential. Marine Drugs 4:3, pages 193-214.
Crossref
Crossref
Su Li, Anne Dodge, Chris Poll & Martin Gosling. 2005. Calcium Signaling, Second Edition. Calcium Signaling, Second Edition
455
485
.
Hyewhon Rhim, Yong Sup Lee, Seong Jun Park, Bong Young Chung & Jae Yeol Lee. (2005) Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers. Bioorganic & Medicinal Chemistry Letters 15:2, pages 283-286.
Crossref
Crossref
Silvina M Tasso, Sung Ch Moon, Luis E Bruno-Blanch & Guillermina L Estiú. (2004) Characterization of the anticonvulsant profile of valpromide derivatives. Bioorganic & Medicinal Chemistry 12:14, pages 3857-3869.
Crossref
Crossref
Takuya Seko, Masashi Kato, Hiroshi Kohno, Shizuka Ono, Kazuya Hashimura, Hideyuki Takimizu, Katsuhiko Nakai, Hitoshi Maegawa, Nobuo Katsube & Masaaki Toda. (2003) Structure–activity study of l-amino acid-based N-type calcium channel blockers. Bioorganic & Medicinal Chemistry 11:8, pages 1901-1913.
Crossref
Crossref
Yuichi Suzuki, Noboru Yamamoto, Yoichi Iimura, Koki Kawano, Teiji Kimura, Satoshi Nagato, Koichi Ito, Makoto Komatsu, Yoshihiko Norimine, Manami Kimura, Tetsuyuki Teramoto, Yoshihisa Kaneda, Takeshi Hamano, Tetsuhiro Niidome & Masahiro Yonaga. (2003) Discovery of novel neuronal voltage-Dependent calcium channel blockers based on emopamil left hand as a bioactive template. Bioorganic & Medicinal Chemistry Letters 13:5, pages 919-922.
Crossref
Crossref
Donald J. AbrahamA. D. Buss, B. Cox & R. D. Waigh. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
847
900
.
Takuya Seko, Masashi Kato, Hiroshi Kohno, Shizuka Ono, Kazuya Hashimura, Yoshifumi Takenobu, Hideyuki Takimizu, Katsuhiko Nakai, Hitoshi Maegawa, Nobuo Katsube & Masaaki Toda. (2002) l-Cysteine based N-type calcium channel blockers: structure–activity relationships of the C-terminal lipophilic moiety, and oral analgesic efficacy in rat pain models. Bioorganic & Medicinal Chemistry Letters 12:17, pages 2267-2269.
Crossref
Crossref
Yoshihiko Norimine, Noboru Yamamoto, Yuichi Suzuki, Teiji Kimura, Koki Kawano, Koichi Ito, Satoshi Nagato, Yoichi Iimura & Masahiro Yonaga. (2002) Enantioselective synthesis of (2S)-5-{4-[2-(4-fluorophenoxy)ethyl]piperazin-1-yl}-2-isopropyl-2-phenyl-pentanenitrile dihydrochloride (E2050) using enzyme-catalyzed kinetic resolution. Tetrahedron: Asymmetry 13:14, pages 1493-1502.
Crossref
Crossref
Takuya Seko, Masashi Kato, Hiroshi Kohno, Shizuka Ono, Kazuya Hashimura, Hideyuki Takimizu, Katsuhiko Nakai, Hitoshi Maegawa, Nobuo Katsube & Masaaki Toda. (2002) Structure–Activity Study of l -Cysteine-Based N-Type Calcium Channel Blockers: Optimization of N- and C-Terminal Substituents. Bioorganic & Medicinal Chemistry Letters 12:6, pages 915-918.
Crossref
Crossref
C. P. Taylor. 2002. CNS Neuroprotection. CNS Neuroprotection
209
244
.
Takuya Seko, Masashi Kato, Hiroshi Kohno, Shizuka Ono, Kazuya Hashimura, Hideyuki Takimizu, Katsuhiko Nakai, Hitoshi Maegawa, Nobuo Katsube & Masaaki Toda. (2001) Structure–Activity Study and Analgesic Efficacy of Amino Acid Derivatives as N-Type Calcium Channel Blockers. Bioorganic & Medicinal Chemistry Letters 11:16, pages 2067-2070.
Crossref
Crossref
Brian Cox. (2000) Calcium channel blockers and pain therapy. Current Review of Pain 4:6, pages 488-498.
Crossref
Crossref
Zhao-Xia Guo, Andrew N Cammidge & David C Horwell. (2000) Dendroid Peptide Structural Mimetics of ω-Conotoxin MVIIA based on a 2(1H)-Quinolinone Core. Tetrahedron 56:29, pages 5169-5175.
Crossref
Crossref
Lain-Yen Hu, Todd R. Ryder, Michael F. Rafferty, Charles P. Taylor, M.Rose Feng, Be-Sheng Kuo, Susan M. Lotarski, George P. Miljanich, Elizabeth Millerman, Krista M. Siebers & Balazs G. Szoke. (2000) The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl]-[4-(3,3-dimethylbutyl)-phenyl]-(3-methyl-but-2-enyl)-amine, an N-type Ca +2 channel blocker with oral activity for analgesia. Bioorganic & Medicinal Chemistry 8:6, pages 1203-1212.
Crossref
Crossref
M Duff Davis & Joann J Schmidt. (2000) In vivo spectrometric calcium flux recordings of intrinsic caudate-putamen cells and transplanted IMR-32 neuroblastoma cells using miniature fiber optrodes in anesthetized and awake rats and monkeys. Journal of Neuroscience Methods 99:1-2, pages 9-23.
Crossref
Crossref
Stefan Menzler, Jack A Bikker, Nirmala Suman-Chauhan & David C Horwell. (2000) Design and biological evaluation of non-peptide analogues of omega-conotoxin MVIIA. Bioorganic & Medicinal Chemistry Letters 10:4, pages 345-347.
Crossref
Crossref
Todd R. Ryder, Lain-Yen Hu, Michael F. Rafferty, Susan M. Lotarski, David M. Rock, Sally J. Stoehr, Charles P. Taylor, Mark L. Weber, George P. Miljanich, Elizabeth Millerman & Balazs G. Szoke. (1999) Structure-activity relationship at the proximal phenyl group in a series of non-peptidyl N-type calcium channel antagonists. Bioorganic & Medicinal Chemistry Letters 9:16, pages 2453-2458.
Crossref
Crossref
Robert M. Schelkun, Po-wai Yuen, Thomas C. Malone, David M. Rock, Sally Stoehr, Balazs Szoke & Katalin Tarczy-Hornoch. (1999) Synthesis and biological activity of substituted bis-(4-hydroxyphenyl)methanes as N-type calcium channel blockers. Bioorganic & Medicinal Chemistry Letters 9:16, pages 2447-2452.
Crossref
Crossref
Raymond S. Norton, Paul K. Pallaghy, Jonathan B. Baell, Christine E. Wright, Michael J. Lew & James A. Angus. (1999) Polypeptide ?-conotoxin GVIA as a basis for new analgesic and neuroprotective agents. Drug Development Research 46:3-4, pages 206-218.
Crossref
Crossref